Influenza vaccination with PREFLUCEL: vaccination motivation and tolarability

Trial Profile

Influenza vaccination with PREFLUCEL: vaccination motivation and tolarability

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Baxter Corporation
  • Most Recent Events

    • 06 Jul 2012 Planned end date 21 Nov 2011 added as reported by German Clinical Trials Register record.
    • 23 Nov 2011 Status changed from not yet recruiting to discontinued as reported by German Clinical Trials Register record.
    • 23 Nov 2011 Actual initiation date 12 Sep 2011 added as reported by German Clinical Trials Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top